Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) Medical University of South Carolina |
---|---|
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00000248 |
The purpose of this study is to evaluate the efficacy and safety of pergolide for treatment of cocaine dependence.
Condition | Intervention | Phase |
---|---|---|
Cocaine-Related Disorders |
Drug: Pergolide |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment |
Official Title: | Dose Response Trial of Pergolide for Cocaine Dependence |
Ages Eligible for Study: | 21 Years to 50 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Please contact site for information.
United States, South Carolina | |
Medical University of South Carolina | |
Charleston, South Carolina, United States, 29425 742 |
Principal Investigator: | Robert Malcolm, M.D. | Medical University of South Carolina |
Study ID Numbers: | NIDA-08355-1, R01-08355-1 |
Study First Received: | September 20, 1999 |
Last Updated: | September 1, 2005 |
ClinicalTrials.gov Identifier: | NCT00000248 |
Health Authority: | United States: Federal Government |
Cocaine-Related Disorders Dopamine Mental Disorders Substance-Related Disorders |
Disorders of Environmental Origin Cocaine Pergolide |
Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs |
Dopamine Agents Dopamine Agonists Pharmacologic Actions |